NewsRoom Articles - Page 2 of 252

ThursdayOct 15, 2026 10:00 am

Experimental Vaccine Delivers Promising Results in Brain Cancer Trial

For more than two decades, no meaningful progress in the way glioblastoma is treated has been made. However, a recent clinical trial testing an experimental vaccine has shown promise by increasing the survival time of GBM patients, particularly those younger than 65 years. The study, which is yet to be peer-reviewed, was conducted through a collaboration between the Comprehensive Cancer Center at Roswell Park and a biotech firm, MimiMax. A press release announcing the results of the trial explains that patients who were given the SurVaxM shots survived longer by 2.5 months when compared to those given a placebo. For…

TuesdayOct 13, 2026 10:00 am

Eliminating “Immune Fog” Shows Promise in Cancer Interception

As scientists race to find effective treatments against cancer, others are working to address tumors before they progress into full-blown cancers. A recent study conducted in the UK has found a possible way to stop cancer in its tracks during its initial stages. A team of researchers at UCL (University College London) conducted this preclinical study. Led by Prof. Sam Janes and Asst. Prof. James Reading, the team found that an “immune fog” forms long before cancer can be detected. This fog, made up of Tregs or regulatory T cells, develops in the lungs and its elevated activity blocks other…

FridayOct 09, 2026 10:00 am

Flu Infections Start Ticking Up Across the US

It is not yet mid-October, but the number of people getting flu is rising across the U.S. Health authorities are warning that the flu season this year could start early, especially in the west of the country. Health authorities usually recommend that people get vaccinated against flu towards the end of October, but the current infection patterns suggest now may be a good time to get your shot. The rationale behind the October recommendation is that full protection from the virus takes approximately two weeks after one gets vaccinated. That duration enables the body to develop a robust immune response…

ThursdayOct 08, 2026 10:00 am

Trump Administration Sends Out $500 Checks for Health Insurance

With the midterms just a few weeks away, the Trump administration has sent $500 checks to individuals that are enrolled on the Healthcare.gov website, a website that is used to select a health insurance policy provider. 30 U.S. states have this site as an option for people who are shopping for a health insurance policy. Ellen Allen, aged 65, is one of the people who received these checks. She resides in West Virginia, one of those 30 states in which the Healthcare.gov site is available. She says she was surprised to receive the check, but adds that the amount is…

WednesdayOct 07, 2026 9:30 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Lucid-MS Trial

New agreement moves innovative Lucid-MS treatment from planning into execution. Proprietary platform is designed around a novel neuroprotective approach that targets demyelination rather than solely modulating the immune system. Thermo Fisher’s clinical research business is a leading global contract research organization, with impressive expertise in central nervous system and MS studies. Most multiple sclerosis (“MS”) drugs work by quieting the immune system. A new partnership shines the spotlight on a different approach — protecting the nerve’s own insulation — and sets up that treatment for a rigorous clinical test. Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company developing therapies for neurodegenerative…

TuesdayOct 06, 2026 10:30 am

Earth Science Tech Inc. (ETST) Building on Synergies Between Healthcare Related Subsidiaries to Generate Dependable and Growing Revenue

Earth Science Tech operates several subsidiaries, including real estate and asset management company Avenvi LLC Avenvi boasts expertise across various segments of the real estate industry, including identifying development opportunities and facilitating end-user property acquisitions Avenvi also manages investments on behalf of ETST and provides the critical physical infrastructure for ETST’s expanding pharmacy operations Earth Science Tech (OTCQB: ETST), a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces, operates Avenvi LLC, a real estate and asset management arm. Like its parent company, Avenvi is diversified, boasting expertise…

TuesdayOct 06, 2026 10:00 am

The Skull Could Be Playing an Immune System Role for the Brain

Conventionally, the skull has largely been known as a structure which forms a protective casing around the brain. However, a recent study conducted by a team at WashU Medicine has found structures similar to lymph nodes inside the bone marrow in the skull, suggesting that the brain may have a local defense system that mobilizes an immune response in case a disease develops in the brain. The study, together with a few other recent discoveries, challenges the long-held view that the immune system and the brain operate separately. Prof. Jonathan Kipnis, an immunology and pathology specialist at WashU Medicine, was…

FridayOct 02, 2026 10:00 am

Blood Samples Could Be Used to Find Cancer-Specific Proteins Needed for Immunotherapy

Immunotherapy, a form of personalized cancer treatment, currently requires a tumor sample to be removed surgically and analyzed so that the personalized treatment needed by the patient can be manufactured. However, getting the needed tumor sample can be challenging in many patients, such as those with tumors in hard-to-access parts of the body or those whose physical condition makes it risky to have surgery done to extract a sample. In some cases, the wait time to have a biopsy is long, which can delay the commencement of needed treatment. A new study suggests that a blood sample could provide a…

ThursdayOct 01, 2026 12:00 pm

Regentis Biomaterials Is Addressing the ‘Short-Term Relief, Long-Term Failure’ Problem in Knee Cartilage Repair

One of the challenges in cartilage repair is that some procedures can provide meaningful short-term pain relief without restoring durable, functional cartilage capable of withstanding the demands of an active joint. Regentis Biomaterials is taking a regenerative approach with GelrinC, a cell-free, off-the-shelf hydrogel designed to temporarily fill cartilage defects while guiding the healthy surrounding tissue to regenerate new, natural and highest hyalin quality cartilage. Recent long-term MRI and peer-reviewed clinical data have provided additional evidence supporting the quality and durability of knee cartilage regenerated with GelrinC, as the company advances its U.S. pivotal trial and commercialization efforts in Europe.…

ThursdayOct 01, 2026 10:00 am

Health Insurance Has Spiked 78% in the US Since 2011

Surging health insurance costs have compelled even healthcare workers to stop getting coverage not only for themselves but also for their staff at private facilities. Premiums climbed 78% between 2011 and 2024, a JAMA study shows. The spiraling costs affecting ordinary Americans haven’t spared healthcare professionals. KFF News provides the example of Ashley Durham, a pharmacist, and her husband Doctor Joshua Durham. The couple owns and runs a medical practice in Idaho, and the rising health insurance costs have compelled them to drop their own policy this year. To get the treatment they need, they have been making withdrawals from…